-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
TCM treatment theory of non-small cell lung cancer: The most basic theory of TCM treatment of non-small cell lung cancer is that when the body's immunity is too weak and the tumor growth capacity is too strong, the imbalance can be adjusted by "strengthening" and "eliminating evil"
TCM treatment theory of non-small cell lung cancer: "Strengthening the body" means enhancing the body's anti-cancer immunity, while "eliminating evil" directly inhibits the growth, proliferation, invasion and migration of tumor cells
Comparison of standard treatment of lung cancer and traditional Chinese medicine treatment:
Herbal medicine, acupuncture, moxibustion, diet therapy, physical exercise TCM can regulate the proliferation, apoptosis, adhesion and migration of cancer cells, and inhibit tumor angiogenesis, change the host immune system and inhibit tumor growth
Adjuvant TCM treatment after surgery: Adjuvant TCM treatment can also prolong the progression-free survival (PFS) of patients with stage II-IIIA NSCLC, reduce mortality, and reduce postoperative tumor recurrence and metastasis
Adjuvant TCM treatment after chemotherapy/radiotherapy: Combination of Chinese herbal medicine: The 1-year survival rate of TCM maintenance treatment is higher than that of maintenance chemotherapy 2.
Adjuvant TCM treatment after targeted therapy: The combined adjuvant therapy of TCM and EGFR-TKI has performed well in clinical effects (including PFS, median survival) and safety
Adjuvant TCM treatment after immunotherapy: Moxibustion with thermal stimulation points Zusanli and Feishu can effectively reduce the ratio of neutrophils to lymphocytes (NLR) in patients with non-small cell lung cancer
The anti-cancer drugs used in traditional Chinese medicine to "strengthen the body" may open another window for people to discover new immunotherapy
Leave a message here